Organoboron
polymers play important roles in biomedical applications.
An ample number of monomers bearing boronic acid derivatives have
been synthesized, particularly focusing on controlled free radical
polymerization methods. Organoboron polymers synthesized by ring-opening
polymerization (ROP) routes are far less explored. We report on the
ROP of boronic acid-installed cyclic carbonates, catalyzed by DBU
from a poly(ethylene glycol) macroinitiator. Controlled polymerization
proceeded to relatively high conversions (∼70%) with low polydispersity.
Deprotection of the copolymer to generate the boronic acid pendant
group was readily achieved by displacement of the protecting group
with free diboronic acid. The resulting amphiphilic copolymers self-assembled
in water into spherical nanoparticles or vesicles, depending on hydrophilic/hydrophobic
ratio. We envision these functional carbonates finding direct applications
for core stabilization of biodegradable amphiphilic assemblies or
in drug and protein encapsulation.
Environmental responsiveness is an
appealing trait of emerging
polymeric materials, as shown for a variety of pH-responsive drug
delivery systems. The chemical versatility of the conjugation site
and conjugate lability to physiologically relevant changes in pH will
largely determine their applicability. Herein, we report on the use
of a drug–polymer complex based on boronic acid-functionalized
polycarbonates (PPBC) as the substrate for the pH-sensitive delivery
of a diol-containing drug, capecitabine (CAPE). Complexation of CAPE
with a PEGylated-PPBC block copolymer, via boronic ester formation,
resulted in amphiphiles capable of self-assembling into spherical
nanoparticles. We examined nanoparticle stability and release kinetics
in neutral and acidic media and relate differences in release profiles
and particle stability with changes to polymer chemistry. Comparison
of complexed nanoparticles with their noncomplex analogues revealed
striking differences in release rate and particle stability. Illustrated
herein for capecitabine, the pH-sensitive dissociation of boronate
esters from PPBCs can be applied in a general manner to diol- or catechol-containing
solutes, demonstrating the utility of these polymers for biomedical
applications.
We have contrasted the behavior of nanoparticles formed by the self-assembly of polymers based on poly(ethylene glycol) (PEG) and poly(D,L-lactide), with linear, linear-dendritic and bottle-brush architectures in biologically relevant media. Polymer PEG content ranged between 14% and 46% w/w, and self-assembly was triggered by a rapid and large change in solvent quality inside a four-stream vortex mixer. We examined nanoparticle interaction with human serum albumin (HSA), and solute release in the presence of fetal bovine serum. Dynamic light scattering data showed that PEG surface brushes of all nanoparticles provided effective steric stabilization, thus limiting their interaction with human serum albumin. Calorimetric experiments revealed that nanoparticle-HSA interaction was relatively weak and enthalpically driven, whereas dynamic light scattering results of incubated nanoparticles showed the absence of larger aggregates for most of the polymers examined. Solute core partitioning was examined by the loss of Forster resonance energy transfer (FRET) from a core-loaded donor-acceptor pair. The rate and magnitude of FRET efficiency loss was strongly dependent on the polymer architecture, and was found to be lowest for the bottle-brush, attributed to its covalent nature. Collectively, these findings are expected to impact the molecular design of increasingly stable polymeric carriers for drug delivery applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.